Assessment of potential cardiotoxic side effects of mitoxantrone in patients with multiple sclerosis

Medizin - Open Access LMU - Teil 13/22 ›

0:00 | Jan 1st, 2005

Previous studies showed that mitoxantrone can reduce disability progression in patients with multiple sclerosis (MS). There is, however, concern that it may cause irreversible cardiomyopathy with redu...Show More